HIGHLIGHTS
- who: Marika Tardella from the Ancona, Italy have published the research: A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease, in the Journal: (JOURNAL)
SUMMARY
Current therapies for RA treatment are worldwide extensively evaluated to determine their effect on lung and RA-ILD patients. Since few years the efficacy of anti-fibrotic drugs used in idiopathic pulmonary fibrosis has been evaluated in RA-ILD patients (Redente et_al 2018). If until recently methotrexate was thought to be toxic for patients with RA-ILD because it could . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.